Billionaires Holding FATE

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 20.6M
    Shares Outstanding

  • 49.07M
    Market Cap

News & Insights

ABOUT

FATE

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.

Here’s Buffett’s Most Recent Acquisition

NEWS

Herbalife: Carl Icahn Comes Out On Top

READ MORE